Life Sciences Review: Weekly Brief
News Letter Subscription
Weekly Brief
Weekly Brief
Thursday, October 22,2026 
Featured Vendors
Jonathan Northrup, Co-founder and CEO
Stingray Therapeutics is developing Vizenpistat, an innate immune checkpoint inhibitor targeting ENPP1 to restore the immune system’s natural response against cancer. Its clinical program explores Vizenpistat alone and in combination with... Read more ‣
Dr. Stan Bernard, President
Bernard Associates helps pharmaceutical organizations navigate complex competition through its proprietary Pharma 2.0 Winning System™ and customized Pharma 2.0 War Games. Its methodology moves beyond traditional competitive intelligence to... Read more ‣
Industry Contributors
By Justin Beardsmore, Chief Technologist – EPR Transformation Programme, Lewisham and Greenwich Nhs Trust
The buildings will also need to be sensitive to the core business of patient care and the environment... Read more ‣
By Michael Baron, Executive Director of Clinical Laboratory Operations, Wisconsin Diagnostic Laboratories
I have been in the clinical laboratory setting for over 34 years and I have noted a shift in lab... Read more ‣
By Brian Thoma, PhD; Director Service Solutions North America, QIAGEN
Don’t wait for your next opportunity; start behaving like you already have it and act accordingly.... Read more ‣
